Pharmacy cooperative American Associated Pharmacies (AAP) revealed on Monday the launch of a definitive agreement for the acquisition of the remaining 50% interest in the joint venture of Arete Pharmacy Network.
Upon completion of the acquisition on 12 September 2018, Arete Pharmacy Network became a wholly owned subsidiary of American Associated Pharmacies.
Arete Pharmacy Network is a quality-focused national Pharmacy Services Administrative Organization (PSAO), concentrated on the success and profitability of independent and community pharmacies. It was formed in 2016 with a total of 2,250 stores and has since grown to over 2,800 pharmacies, making the fourth largest PSAO in the nation. In December 2016, it expanded its geographical footprint through the acquisition of RxPride to extend the benefits of its programmes and services.
AAP in partnership with its subsidiaries provide the tools and resources needed for members to improve their bottom line and differentiate themselves from competitors. The members not only receive savings on brand prescriptions, generic prescriptions and OTC products through the API warehouse and their negotiated prime vendor agreement, but they receive negotiated competitive managed-care contracts through the Arete Pharmacy Network.
CivicaScript to distribute biosimilar for chronic inflammatory conditions
Mallinckrodt and Endo complete merger
Zenara Pharma's Sertraline Hydrochloride Capsules generic receives US FDA approval
EQT agrees to acquire majority stake in Adalvo
Mallinckrodt receives Irish High Court ruling to combine with Endo Inc
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CivicaScript introduces low-cost multiple sclerosis treatment
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
Avera joins Civica to help maintain drug supplies
Apotex launches generic version of Tasigna in US market
CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension
Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets